Patents Assigned to METRO NORTH HOSPITAL AND HEALTH SERVICE
  • Patent number: 11879012
    Abstract: This invention relates generally to a method of inhibiting epithelial cell proliferation including the treatment of conditions associated with aberrant epithelial cell proliferation in mammals, including animals and humans. The present invention is particularly relevant for the treatment of cancer.
    Type: Grant
    Filed: March 4, 2019
    Date of Patent: January 23, 2024
    Assignees: METRO NORTH HOSPITAL AND HEALTH SERVICE
    Inventors: Peter Gillies, Damien G. Harkin, Neil A. Richardson